ss109
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 5, 2022 (NCT05651061)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Coagulation factor IXINHIBITOR
F9 inhibitor
- Coagulation factor VIIIINHIBITOR
F8 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06010953 | Phase 1/Phase 2 (Phase 2) | Oct 12, 2023 | Jiangsu Gensciences lnc. |
| NCT05651061 | Phase 1 | Dec 5, 2022 | Chinese Academy of Medical Sciences, Jiangsu Gensciences lnc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Gensciences lnc. | For profit | 2 | 2 | 2 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1